(Q71731863)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

In vitro activity of trovafloxacin in combination with ceftazidime, meropenem, and amikacin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

1 reference

1 reference

D Milatovic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

C Wallrauch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 August 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

688-693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01691162

20 October 2019

exact match

0 references

cites work

In vitro activity of the new fluoroquinolone CP-99,219.

1 reference

12 December 2020

Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.

1 reference

12 December 2020

In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.

1 reference

12 December 2020

Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.

1 reference

12 December 2020

Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods

1 reference

12 December 2020

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

12 December 2020

Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches

1 reference

12 December 2020

Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains

1 reference

12 December 2020

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

1 reference

12 December 2020

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

1 reference

12 December 2020

Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa

1 reference

12 December 2020

Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens

1 reference

12 December 2020

In vitro activity of ciprofloxacin against aerobic gram-negative bacteria

1 reference

12 December 2020

Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01691162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894583%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference